MIRA INFORM REPORT

 

 

Report Date :

10.09.2014

 

IDENTIFICATION DETAILS

 

Name :

ORCHEV PHARMA PRIVATE LIMITED

 

 

Registered Office :

Rangoli, 1st Floor, Opposite Jaynath Petrol Pump, Gondal Road, Rajkot – 360 002, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

28.06.1989

 

 

Com. Reg. No.:

04-012430

 

 

Capital Investment / Paid-up Capital :

Rs.9.990 millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ1989PTC012430

 

 

PAN No.:

[Permanent Account No.]

AAACO3086D

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer, Exporter and Importer of bulk drugs.

 

 

No. of Employees :

61 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track record.

 

General financial position of the company seems to be sound and healthy. Profitability of the company is fair.

 

However, trade relations are fair. Business is active. Payment terms are recorded to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

As per the latest IMF study, the total weigh of emerging markets in the GDP of the world on a purchasing power parity basis has seen a sizeable shift. It highlights how as against 51 % in 2005, the emerging economies now account for close to 56 % of the global purchasing power GDP as per the latest survey. And with the emerging economies growing at a faster rate than their developed counterparts, there are every possibility that the their share goes up further in the coming years.  China may surpass the US over the next few years.

 

Politics and economics are very intricately connected. They tend to influence each other in ways that could be very complex and far-reaching. The prospects of the India’s economy have been seriously compromised due to political corruption. High inflation, poor standard of living are to a great extent a result of rampant corruption in the country. China on the other hand, seems to be facing diametrically opposite challenge. American hedge fund manager Jim Chanos has been keenly following the political and economic development in the dragon economy and has figured out something that is quite worrying. He is of the view that the Chinese economy could be heading toward trouble on account of new Chinese President Xi Jingping’s very aggressive anti-corruption drive. Chanos believes tat many things such as apartment sales, luxury products, etc. were largely bought with dirty money. And it is now beginning to impact consumption. This may indeed be bad news for an economy that is struggling to transition from an investment-driven export-oriented economy to a domestic consumption-driven economy.

 

A study published by Firstpost has revealed that asset classes like real estate and equities were the biggest beneficiaries of the liberalization policies.  A firm called Ciane Analytics studied returns from assets including equities, gold, fixed deposits, G-Secs and real estate since 1991. Real estate outperformed every other asset classes during the 23-year period with an annualized return of 20 % ! Equities came in second with annualized return of 15.5 % ! However, while these returns may seem mouthwatering, the fact is that the return from equities adjusted for inflation came down to just 7.1 %.

 

Some brief news are as under

. R-Power to buy Jaypee’s hydro assets

. Investors await justice in NSEL case

. India seeks MFN status from Pakistan ahead of meeting

. Ukrain’s clashes with rebels hinder MH17 crash investigation

. India exploring merger of state-owned hydro PSUs

..Higher costs weigh down profit growth to slowest in 9 quarters

..Wal-Mart to expand wholesale business in India

. GMR group moves to strengthen balance sheet

. Central Bank to sell 4 % stake to Life Insurance Corporation

. Tata Chemicals plans to raise up to Rs 10000 mn.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Cash Credit : BBB-

Rating Explanation

Moderate degree of safety and moderate credit risk.

Date

August, 2013

 

Rating Agency Name

ICRA

Rating

Credit Exposure Limit: A3

Rating Explanation

Moderate degree of safety and high credit risk.

Date

August, 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Pangh Rathod 

Designation :

Export Department

Contact No.:

91-281-2365731

Date:

09.09.2014

 

 

LOCATIONS

 

Registered Office :

Rangoli, 1st Floor, Opposite Jaynath Petrol Pump, Gondal Road, Rajkot – 360 002, Gujarat, India

Tel. No.:

91-281-2365731/ 2365732

Fax No.:

91-281-2365733

E-Mail :

info@orchev.com

csroc.mail@hjamnadas.com

Website:

http://www.orchev.com

Location:

Owned

 

 

Factory:

Shapar Industrial Area, Rajkot-Gondal Highway, Veraval, District Rajkot – 360 024, Gujarat, India

Tel. No.:

91-2827-252114/ 252115

Fax No.:

91-2827-252113

 

 

DIRECTORS

 

AS ON 28.09.2013

 

Name :

Mr. Viren Vasantbhai Patel

Designation :

Director

Address :

Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360 005, Gujarat, India

Date of Appointment :

01.06.2006

DIN No.:

00544034

 

 

Name :

Mr. Chiragbhai Vasantbhai Patel

Designation :

Director

Address :

Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360 005, Gujarat, India

Date of Appointment :

01.08.2006

DIN No.:

00544051

 

 

Name :

Mr. Vasantlal Odhavjibhai Bhalodia

Designation :

Director

Address :

Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360 005, Gujarat, India

Date of Appointment :

28.06.1989

DIN No.:

00544069

 

 

Name :

Mrs. Kanchanben Vasantlal Bhalodia

Designation :

Director

Address :

Sadguru Tower, Block No. B/9, Opposite Gondhiya Hospital, Kalawad Road, City Rajkot – 360 005, Gujarat, India

Date of Appointment :

03.10.1992

DIN No.:

00544082

 

 

KEY EXECUTIVES

 

Name :

Mr. Pangh Rathod 

Designation :

Export Department

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 28.09.2013

 

Names of Shareholders

 

 

No. of Shares

Vasantlal Odhavjibhai Bhalodia

 

995

Vasantlal Odhavjibhai Bhalodia (As Karta of Vasantial O. Bhalodia HUF)

 

1544

Kanchanben Vasantlal Bhalodia

 

707

Anilbhai Sridhar Kane

 

104

Kasturben Amrutlal Patel

 

110

Prafulkumar Vinaychandra Kamdar

 

110

Dineshkumar Harjivanbhai Patel

 

100

Ciragbhai Vasantbhai Patel

 

2568

Viren Vasantlal Patel

 

3006

Dipti Chiragbhai Patel

 

457

Bharatbhai T. Kalawadia

 

78

Nitinbhai T. Kalawadia

 

78

Ameeben Virenbhai Patel

 

133

Total

 

9990

 

AS ON 28.09.2013

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

96.93

Others

 

3.07

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Importer of bulk drugs.

 

 

Exports :

 

Products :

Bulk drugs

Countries :

·         Asian Countries

·         Latin America

·         Middle East

·         UK

·         Brazil

·         Europe

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash and Advance Payment  

 

 

Purchasing :

Cash and Advance Payment  

 

 

PRODUCTION STATUS (AS ON 31.03.2011):

 

Particulars

Unit

Licensed Capacity

Annual Installed Capacity

Actual Production

Ranitidine HCL

M.T.

1800.000

540.000

371.215

 

 

GENERAL INFORMATION

 

Customer:

·         Wholesalers

·         Retailers

·         End Users

 

 

No. of Employees :

61 (Approximately)

 

 

Bankers :

·         State Bank of India, Bhaktinagar Branch, Dhebar Road, Rajkot – 360 001, Gujarat, India

·         HDFC Bank Limited

·         UCO Bank

 

 

Facilities :

Secured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

- From Banks

0.645

0.000

SHORT TERM BORROWINGS

 

 

Cash Credit From Banks

 

 

1. State Bank of India, C.C. A/c No.00000056068131677

(Secured by hypothecation of Raw Material, Finished Goods and Work in Progress, Limit of Rs.490.00 Lacs)

12.562

6.485

2. State Bank of India - Packing Credit in Foreign Currency

A/c No.00000031200662659

(Secured by hypothecation of Raw Material, Finished Goods and Work in Progress, Limit of Rs.49.000 millions Lacs) (U.S.$ 174100 @ 50.96)

14.739

8.872

Total

27.946

15.357

 

 

 

Banking Relations :

 

 

 

Auditors :

 

Name :

H. Jamnadas and Company

Chartered Accountants

Address :

50, Janta Society, Opposite LIC Building, Mahila College Chowk, Tagore Road, Rajkot – 360 001, Gujarat, India

PAN No.:

AABFH2320P

 

 

CAPITAL STRUCTURE

 

AS ON 28.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs.1000/- each

Rs.10.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

9990

Equity Shares

Rs.1000/- each

Rs.9.990 millions

 

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2013

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1) Shareholders' Funds

 

 

 

(a) Share Capital

9.990

9.990

9.990

(b) Reserves & Surplus

118.614

107.901

102.552

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

128.604

117.891

112.542

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) Long-term borrowings

45.599

12.113

14.356

(b) Deferred tax liabilities (Net)

1.604

1.821

1.228

(c) Other long term liabilities

0.000

0.000

0.000

(d) Long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

47.203

13.934

15.584

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

27.301

15.357

27.205

(b) Trade payables

41.277

38.208

6.873

(c) Other current liabilities

7.261

0.914

2.584

(d) Short-term provisions

14.696

6.979

13.262

Total Current Liabilities (4)

90.535

 61.458

49.924

 

 

 

 

TOTAL

266.342

193.283

178.050

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

54.807

51.350

39.964

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

1.879

6.241

2.485

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.094

0.094

0.094

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

1.156

1.142

0.940

Total Non-Current Assets

57.936

58.827

43.483

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

80.688

54.180

67.912

(c) Trade receivables

86.611

40.620

37.953

(d) Cash and cash equivalents

2.691

4.389

2.727

(e) Short-term loans and advances

0.000

0.000

0.000

(f) Other current assets

38.416

35.267

25.975

Total Current Assets

208.406

134.456

134.567

 

 

 

 

TOTAL

266.342

193.283

178.050

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

31.03.2011

 

SALES

 

 

 

 

 

Income

386.163

279.697

255.139

 

 

Other Income

 

 

 

 

 

TOTAL                                     (A)

386.163

279.697

255.139

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

354.837

259.884

229.357

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                     (B)

354.837

259.884

229.357

 

 

 

 

 

Less

PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

31.326

19.813

25.782

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

3.730

3.022

4.645

 

 

 

 

 

 

PROFIT/ (LOSS) TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

27.596

16.791

21.137

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

8.377

6.499

5.701

 

 

 

 

 

 

PROFIT/ (LOSS) BEFORE TAX (E-F)                  (G)

19.219

10.292

15.436

 

 

 

 

 

Less

TAX                                                                  (H)

6.753

3.202

5.118

 

 

 

 

 

 

PROFIT/ (LOSS) AFTER TAX (G-H)                   (I)

12.466

7.090

10.318

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

87.850

83.052

75.606

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend

1.499

1.499

1.998

 

 

Corporate Dividend Tax

0.254

0.243

0.324

 

 

General Reserve

0.625

0.550

0.550

 

BALANCE CARRIED TO THE B/S

97.938

87.850

83.052

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Sales

211.237

137.447

170.270

 

TOTAL EARNINGS

211.237

137.447

170.270

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

1247.85

709.71

NA

 

 

Particulars

 

 

 

31.03.2014

Sales Turnover (Approximately)

 

 

447.500

 

 

 

 

 

The above information has been parted by Mr. Naitik (Accounts Department).

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2013

31.03.2012

31.03.2011

PAT / Total Income

(%)

3.23

2.53

4.04

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

7.27

5.51

8.80

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.15

0.09

0.14

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.57

0.23

0.37

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.30

2.19

2.70

 


 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns.)

(INR in Mlns.)

(INR in Mlns.)

Share Capital

9.99

9.99

9.99

Reserves & Surplus

102.552

107.901

118.614

Net worth

112.542

117.891

128.604

 

 

 

 

Long-term borrowings

14.356

12.113

45.599

Short term borrowings

27.205

15.357

27.301

Total borrowings

41.561

27.470

72.900

Debt/Equity ratio

0.369

0.233

0.567

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Total Income

255.139

279.697

386.163

 

 

9.625

38.065

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2011

31.03.2012

31.03.2013

 

(INR in Mlns)

(INR in Mlns)

(INR in Mlns)

Total Income

255.139

279.697

386.163

Profit

10.318

7.090

12.466

 

4.04%

2.53%

3.23%

 


 

LOCAL AGENCY FURTHER INFORMATION

 

CURRENT MATURITIES OF LONG-TERM DEBT DETAILS:

 

Particulars

31.03.2013

31.03.2012

31.03.2011

 

(Rs. In Millions)

Current maturities of long-term debt

0.430

0.000

NA

 

 

 

 

Total

0.430

0.000

NA

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

OPERATION AND PROSPECTS:

 

During the current year of operations, the Company has achieved Revenue from Operation and Other Income of Rs.386.163 millions as against Rs.279.697 millions during the previous year. The production of Ranitidine for the year ended 31st March, 2013 was 449.899 M.T. The Company has earned a Profit of Rs.31.326 millions before depreciation and interest and a Profit of Rs.19.219 millions after providing for depreciation and interest. The Directors are trying their level best to improve the performance of the Company in terms of Turnover and Profitability. The prospects of the Company’s business are bright and positive.

 

INDEX OF CHARGES

 

S.No.

Charge ID

Date of charge creation/modification

Charge Amount Secured

Charge Holder

Address

Service Request Number (SRN)

1

10258643

01/05/2013 *

66,500,000.00

STATE BANK OF INDIA

BHAKTINAGAR BRANCH, DHEBAR ROAD, RAJKOT, GUJARAT - 360001, INDIA

B74739806

 

* Date of charge modification

 

 

Unsecured Loans

31.03.2013

(Rs. in Millions)

31.03.2012

(Rs. in Millions)

LONG TERM BORROWINGS

 

 

- From Directors

39.895

10.597

- From Shareholders and Directors' Relatives

5.059

1.516

Total

44.954

12.113

 

 

FIXED ASSETS

 

Direct Assets

·         Land

·         Factory Building

·         Factory Furniture

·         Factory Air Conditioner 

·         Road and Site Development

·         Plant and Machinery

·         Electrification

·         Laboratory Equipment

·         Microbiology laboratory

·         Material Handling Lift

·         Storage Tanks  Chemicals

·         Weighing Scale

·         Sulphuric Acid Tank

Indirect Assets

·         Other Building

·         Office Equipment

·         Office Attendance Machine

·         Office Air Conditioners

·         Office Furniture

·         Motor Car

·         Innova Car

·         Car  Hyundai i10

·         Car  Honda Civic

·         Two Wheelers

·         Other Misc. Assets

·         Canteen Utensils

·         Refrigerator

·         Television Set

·         Computer

·         Tractor

·         Ups and Battery

·         Mobile Phone

·         Telephone Instruments

·         Water Storage Tank

·         Water Cooler

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.43

UK Pound

1

Rs.97.25

Euro

1

Rs.77.93    

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

KVT

 

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.